Endo Announces Initiation Of Two Pivotal Phase 3 Clinical Trials Of … – PR Newswire (press release)


Philadelphia Business Journal

Endo Announces Initiation Of Two Pivotal Phase 3 Clinical Trials Of …
PR Newswire (press release)
DUBLIN, Feb. 6, 2018 /PRNewswire/ — Endo International plc (NASDAQ: ENDP) today announced the initiation of two identical Phase 3 RELEASE* clinical trials of collagenase clostridium histolyticum (CCH) for the treatment of cellulite. The multicenter
Endo Announces Initiation Of Two Pivotal Phase 3 Clinical Trials Of Collagenase Clostridium Histolyticum For The …Markets Insider

all 3 news articles »

Read more: www.prnewswire.com

About the Author AdelinaDuh

Leave a Comment: